Literature DB >> 26869297

Molecular Risk Factors for Schizophrenia.

Shira Modai1, Noam Shomron2.   

Abstract

Schizophrenia (SZ) is a complex and strongly heritable mental disorder, which is also associated with developmental-environmental triggers. As opposed to most diagnosable diseases (yet similar to other mental disorders), SZ diagnosis is commonly based on psychiatric evaluations. Recently, large-scale genetic and epigenetic approaches have been applied to SZ research with the goal of potentially improving diagnosis. Increased computational analyses and applied statistical algorithms may shed some light on the complex genetic and epigenetic pathways contributing to SZ pathogenesis. This review discusses the latest advances in molecular risk factors and diagnostics for SZ. Approaches such as these may lead to a more accurate definition of SZ and assist in creating extended and reliable clinical diagnoses with the potential for personalized treatment.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  biomarker; diagnosis; epigenetic; genetic; high throughput; risk factor; schizophrenia

Mesh:

Year:  2016        PMID: 26869297     DOI: 10.1016/j.molmed.2016.01.006

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  12 in total

1.  Disturbed Prefrontal Cortex Activity in the Absence of Schizophrenia-Like Behavioral Dysfunction in Arc/Arg3.1 Deficient Mice.

Authors:  Xiaoyan Gao; Jasper Grendel; Mary Muhia; Sergio Castro-Gomez; Ute Süsens; Dirk Isbrandt; Matthias Kneussel; Dietmar Kuhl; Ora Ohana
Journal:  J Neurosci       Date:  2019-09-05       Impact factor: 6.167

2.  Immune Activation in Pregnant Rats Affects Brain Glucose Consumption, Anxiety-like Behaviour and Recognition Memory in their Male Offspring.

Authors:  Cyprien G J Guerrin; Alexandre Shoji; Janine Doorduin; Erik F J de Vries
Journal:  Mol Imaging Biol       Date:  2022-04-05       Impact factor: 3.484

Review 3.  Asenapine Transdermal Patch for the Management of Schizophrenia.

Authors:  Maxine Zhou; Sahar Derakhshanian; Alexander Rath; Sarah Bertrand; Caroline DeGraw; Rachel Barlow; Aja Menard; Adam M Kaye; Jamal Hasoon; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2020-09-14

4.  Integrative In Silico Analysis of Genome-Wide DNA Methylation Profiles in Schizophrenia.

Authors:  Diego A Forero; Yeimy González-Giraldo
Journal:  J Mol Neurosci       Date:  2020-05-26       Impact factor: 3.444

Review 5.  Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor.

Authors:  Fabiana Maria das Graças Corsi-Zuelli; Fernanda Brognara; Gustavo Fernando da Silva Quirino; Carlos Hiroji Hiroki; Rafael Sobrano Fais; Cristina Marta Del-Ben; Luis Ulloa; Helio Cesar Salgado; Alexandre Kanashiro; Camila Marcelino Loureiro
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

6.  MicroRNA-Mediated Regulation of ITGB3 and CHL1 Is Implicated in SSRI Action.

Authors:  Keren Oved; Luba Farberov; Avial Gilam; Ifat Israel; Danielle Haguel; David Gurwitz; Noam Shomron
Journal:  Front Mol Neurosci       Date:  2017-11-02       Impact factor: 5.639

7.  Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population.

Authors:  Junxiao Miao; Lu Liu; Ci Yan; Xiaotong Zhu; Mengqi Fan; Peitong Yu; Keming Ji; Yinglin Huang; Yuan Wang; Gang Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-28       Impact factor: 2.570

8.  Key role for lipids in cognitive symptoms of schizophrenia.

Authors:  Dorien A Maas; Marijn B Martens; Nikos Priovoulos; Wieteke A Zuure; Judith R Homberg; Brahim Nait-Oumesmar; Gerard J M Martens
Journal:  Transl Psychiatry       Date:  2020-11-12       Impact factor: 6.222

9.  Genetic findings are challenging the symptom-based diagnostic classification system of mental disorders.

Authors:  Chen Zhang
Journal:  Shanghai Arch Psychiatry       Date:  2016-02-25

Review 10.  Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.

Authors:  Raúl Delgado-Morales; Roberto Carlos Agís-Balboa; Manel Esteller; María Berdasco
Journal:  Clin Epigenetics       Date:  2017-06-29       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.